MedPath

Evaluation of Brain FDG-PET as Part of a Complete Medical Checkup

Not Applicable
Conditions
Alzheimer disease
Registration Number
JPRN-UMIN000013631
Lead Sponsor
School of medicine, Keio University Department of neurology
Brief Summary

In 35 cases, three cases show abnormal brain metabolism in FDG -PET.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Disagree

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Each 30 subjects who have abnormal metabolism on an FDG-PET scan will be monitored for a long term to assess changes in clinical features and cognitive function over time.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath